GKV Capital Management Co., Inc.
Source: SEC Form 13F · as of Mar 2026GKV Capital Management Co., Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $49.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$49.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 28,846 | $25.1M |
| AMGNAMGEN INC | 22,982 | $7.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 8,345 | $3.9M |
| ABBVAbbVie Inc. | 17,029 | $3.7M |
| IDXXIDEXX LABORATORIES INC /DE | 6,450 | $3.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,110 | $2.2M |
| JNJJOHNSON & JOHNSON | 7,012 | $1.4M |
| AZNASTRAZENECA PLC | 7,342 | $1.4M |
| PMPhilip Morris International Inc | 3,400 | $551K |
| MRKMerck & Co., Inc. | 500 | $45K |
| ABTABBOTT LABORATORIES | 200 | $27K |
| MRNAModerna, Inc. | 17 | $482 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.